| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.0M | +234.2% |
| Cost of Revenue | $3.7M | +337.7% |
| Gross Profit | $239K | -28.9% |
| R&D Expense | $0 | -100.0% |
| SG&A Expense | $2.6M | +168.9% |
| Operating Income | -$7.1M | -326.9% |
| Interest Expense | $47K | -77.5% |
| Pre-tax Income | -$7.1M | -281.4% |
| Income Tax | $0 | — |
| Net Income | -$7.1M | -281.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $548K | -41.3% |
| Accounts Receivable | $479K | +231.8% |
| Inventory | $645K | +224.3% |
| Current Assets | $1.9M | -9.9% |
| Total Assets | $9.5M | +25.3% |
| Current Liabilities | $1.5M | -63.5% |
| Long-term Debt | $143K | -15.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.4M | -497.9% |
| Capital Expenditures | $104K | +29.9% |
| Investing Cash Flow | -$64K | +20.1% |
| Financing Cash Flow | $4.0M | +132.2% |
| Free Cash Flow | -$4.5M | -451.8% |
| Total Liabilities |
| $1.9M |
| -59.1% |
| Stockholders' Equity | $7.7M | +165.6% |